GeneDx Holdings Corp.: Piper Sandler cuts target price to $65 from $95
WGS•Piper Sandler cut its target price for GeneDx Holdings Corp. to $65 from $95.
Related News
Cemex Ventures to host European Pitch Day with five construction startup finalists
CX•
Oil rebounds as Hormuz shipping attacks blunt hopes for Iran truce
USO•
Western Union announces termination of agreement to acquire Intermex
WU•
Dingdong to report third-quarter financial results
DDL•
GAP declares Q4 FY2026 dividend of $0.175 per share payable January 27, 2027
GPS•